CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: Therefore, LSCs in blast phase of CML can show different immunophenotypes: Lin–CD34+CD38−, Lin–CD34+CD38+ or even CD34−, like LSCs in AML (62).